Portfolio company
Hema.to
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops clinical software that uses artificial intelligence to automate the analysis of flow cytometry data for diagnostic laboratories.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
Spotlight Pathology
This company develops artificial intelligence software for clinicians to analyse digital pathology images for the diagnosis and classification of blood cancers.
Kiro
This company develops an artificial intelligence platform that analyses laboratory test results for healthcare providers and patients.
PhenoTA
This company develops automated blood testing technology using Raman spectroscopy and artificial intelligence for next-generation hematology laboratories.
iCardio.ai
This company develops artificial intelligence software that automates the analysis and interpretation of cardiac ultrasound images for clinicians and medical device manufacturers.
Health Triage
This company develops artificial intelligence software for early cancer detection and clinical diagnosis to assist healthcare facilities and medical professionals.
Cancilico
Cancilico develops AI-powered software for automated bone marrow cell classification and counting to assist diagnostic laboratories in identifying blood cancers.
HeartFlow
This company provides AI-driven software for clinicians to diagnose and manage coronary artery disease using non-invasive 3D models of heart blood flow.
